RECOURSE versus CORRECT and CONCUR trials evaluating regorafenib in metastatic CRC at Annual Meeting GI 2016

Alan P. Venook, MD of University of California San Francisco discusses RECOURSE versus CORRECT and CONCUR trials evaluating regorafenib in metastatic CRC at ASCO GI 2016